Eduardo Rene Salas - 20 Apr 2022 Form 3 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
20 Apr 2022
Net transactions value
$0
Form type
3
Filing time
21 Apr 2022, 16:52:40 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

No securities are beneficially owned.